Hüsnü Pullukçu

3.0k citations
161 papers · 2.2k · 1 hit paper · h-index 23

Impact in

Papers in

    • Hepatitis B Virus Studies 14
    • Urinary Tract Infections Management 13
    • Respiratory viral infections research 9
    • Pneumonia and Respiratory Infections 8
    • Antifungal resistance and susceptibility 14

Hüsnü Pullukçu

137 papers receiving 2.1k citations

Hüsnü Pullukçu's Hit Papers

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey 2021 · 701 citations
7010+1+3Years since publication200400600

Peers

Hüsnü Pullukçu
Comparison fields: 5 of 118
  • Molecular Medicine 263
  • Applied Microbiology and Biotechnology 95
  • Infectious Diseases 894
  • Health 217
  • Epidemiology 718
Replace Tansu Yamazhan with:
Tansu Yamazhan Türkiye
Meltem Isikgoz Tasbakan Türkiye
Pritish K. Tosh United States
Minn M. Soe United States
Jennie H. Kwon United States
Bilgül Mete Türkiye
Robert M. Rakita United States
Paul Loubet France
Çigdem Ataman Hatipoğlu Türkiye
Bibiana Chazan Israel
Hüsnü Pullukçu relative to Tansu Yamazhan Türkiye Tansu Yamazhan's profile →
Citations per field
00.5×1.5×2.1×
Tansu Yamazhan · 1×
Citations per year

Countries citing papers authored by Hüsnü Pullukçu

Since Specialization
Citations

This map shows the geographic impact of Hüsnü Pullukçu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hüsnü Pullukçu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hüsnü Pullukçu more than expected).

Fields of papers citing papers by Hüsnü Pullukçu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hüsnü Pullukçu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hüsnü Pullukçu. The network helps show where Hüsnü Pullukçu may publish in the future.

Co-authors

The 25 scholars most cited alongside Hüsnü Pullukçu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hüsnü Pullukçu Line = papers co-authored together Hüsnü Pullukçu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
Hit paper breakdown →
2021701
2 2006148
3 201068
4 201166
5 201255
6 201053
7 202250
8
HPV vaccine awareness and willingness of first-year students entering university in Western Turkey.
201049
9
Pooled analysis of 857 published adult fever of unknown origin cases in Turkey between 1990-2006.
200744
10 202143
11 200743
12 201539
13 201135
14 201430
15 202029
16 202028
17 202227
18 201326
19 201126
20
Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey.
200925

About Hüsnü Pullukçu

Hüsnü Pullukçu is a scholar working on Epidemiology, Infectious Diseases, Molecular Medicine, Hepatology and Applied Microbiology and Biotechnology, having authored 161 papers that have together received 2.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (20 papers), Hepatitis B Virus Studies (14 papers), Antifungal resistance and susceptibility (14 papers), Urinary Tract Infections Management (13 papers), Hepatitis C virus research (13 papers), Antibiotic Use and Resistance (13 papers), Respiratory viral infections research (9 papers) and Pneumonia and Respiratory Infections (8 papers). The work is most often cited by research in Molecular Medicine (263 citations), Applied Microbiology and Biotechnology (95 citations), Infectious Diseases (894 citations), Health (217 citations) and Epidemiology (718 citations). Hüsnü Pullukçu has collaborated with scholars based in Türkiye, United States and Italy. Frequent co-authors include Meltem Isikgoz Tasbakan, Tansu Yamazhan, Sercan Ulusoy, Oğuz Reşat Sipahi, Bilgin Arda, Sabire Şöhret Aydemir, Oğuz Reşat Sıpahı, Hilal Sipahi, Raika Durusoy and Candan Çiçek. Their work appears in journals such as International Journal of Infectious Diseases, Journal of Chemotherapy, International Journal of Antimicrobial Agents, International Journal of Clinical Practice and BMC Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact